{"lastName":"De la Fuente","objectUrn":"urn:li:member:416454014","geoRegion":"Madrid, Community of Madrid, Spain","fullName":"I\u00f1igo De la Fuente","firstName":"I\u00f1igo","currentPositions":[{"companyName":"Merck Life Science","description":"Support and guide Emerging Biotech Companies with Merck's cutting edge products and services to speed new therapies (Viral-Gen Therapy, Cell Therapy, CAR-T, CRISPR-CAS, ADCs...) from preclinical through Phase 3 Production. My role is to be a resource and a connector, as I provide application and product support, training or a connection to an expert","title":"Customer Application Consultant for Emerging Biotech (Italy, Spain & Portugal)","companyUrnResolutionResult":{"employeeCountRange":"10001+","headquarters":{"country":"Germany","city":"Darmstadt","postalCode":"64293","line1":"Frankfurter Stra\u00dfe 250"},"website":"http:\/\/www.sigmaaldrich.com","flagshipCompanyUrl":"https:\/\/www.linkedin.com\/company\/merck-life-science\/","industry":"Biotechnology Research"},"companyUrn":"urn:li:fs_salesCompany:16233341","tenureAtCompany":{"numYears":2,"numMonths":8},"startedOn":{"month":10,"year":2021}}],"entityUrn":"urn:li:fs_salesProfile:(ACwAABjSlX4BsoixP-OHtyD0MMAREQeLbZSZBho,NAME_SEARCH,2ACs)","profilePictureDisplayImage":{"artifacts":[{"width":100,"fileIdentifyingUrlPathSegment":"100_100\/0\/1637599573802?e=1723075200&v=beta&t=Nv6ONzSGZ8__8PkDEgi999dAHe4QxZ5bbaul1E7EkOo","height":100},{"width":200,"fileIdentifyingUrlPathSegment":"200_200\/0\/1637599573802?e=1723075200&v=beta&t=HrtOWV2lnZ_L8snjaagmsb7CMBIytiWP3hS5zs_VyqA","height":200},{"width":400,"fileIdentifyingUrlPathSegment":"400_400\/0\/1637599573802?e=1723075200&v=beta&t=SVgzWndQV7WDoxge3YuRDBT3rZJw4BbOyte_lUDd2kY","height":400},{"width":800,"fileIdentifyingUrlPathSegment":"800_800\/0\/1637599573802?e=1723075200&v=beta&t=dEWoaNCjbXL64IGIlv2V13ODzrgw12OFedr8a9Nu6_8","height":800}],"rootUrl":"https:\/\/media.licdn.com\/dms\/image\/C5603AQEFqFyAZoNGIw\/profile-displayphoto-shrink_"},"projects":[],"contactInfo":{},"industry":"Biotechnology Research","educations":[{"endedOn":{"year":2020},"degree":"Master of Business Administration - MBA","eduId":625888111,"schoolUrn":"urn:li:fs_salesSchool:47844","school":"urn:li:fs_salesSchool:47844","fieldsOfStudy":["M\u00e1ster en el \u00c1rea M\u00e9dico-Cientifica en la Industria Bio-farmac\u00e9utica"],"schoolName":"Universidad de Alcal\u00e1","startedOn":{"year":2019}},{"endedOn":{"year":2017},"degree":"Master en Biotecnolog\u00eda","eduId":372867011,"schoolUrn":"urn:li:fs_salesSchool:166613","school":"urn:li:fs_salesSchool:166613","schoolName":"Universidad Aut\u00f3noma de Madrid","startedOn":{"year":2016}},{"endedOn":{"year":2016},"degree":"Grado en Biotecnologia","eduId":317762042,"schoolUrn":"urn:li:fs_salesSchool:1289559","school":"urn:li:fs_salesSchool:1289559","fieldsOfStudy":["Probiogenomica"],"schoolName":"Universit\u00e0 degli Studi di Parma","startedOn":{"year":2015}},{"endedOn":{"year":2016},"degree":"Grado en Biotecnologia","eduId":276775771,"schoolUrn":"urn:li:fs_salesSchool:15248508","school":"urn:li:fs_salesSchool:15248508","fieldsOfStudy":["Biotecnolog\u00eda industrial"],"schoolName":"Universidad del Pa\u00eds Vasco\/Euskal Herriko Unibertsitatea","startedOn":{"year":2012}}],"skills":[{"numOfEndorsement":8,"name":"Ingl\u00e9s"},{"numOfEndorsement":8,"name":"Biotecnolog\u00eda"},{"numOfEndorsement":7,"name":"Industria biotecnol\u00f3gica"},{"numOfEndorsement":2,"name":"Investigaci\u00f3n"},{"numOfEndorsement":3,"name":"Biolog\u00eda molecular"},{"numOfEndorsement":2,"name":"microbiology"},{"numOfEndorsement":2,"name":"PCR"},{"numOfEndorsement":2,"name":"bioinformatics"},{"numOfEndorsement":2,"name":"Microsoft Office"},{"numOfEndorsement":2,"name":"Microsoft Word"},{"numOfEndorsement":2,"name":"Microsoft Excel"},{"numOfEndorsement":2,"name":"Microsoft PowerPoint"},{"numOfEndorsement":2,"name":"Python"},{"numOfEndorsement":3,"name":"Oratoria"},{"numOfEndorsement":3,"name":"Trabajo en equipo"},{"numOfEndorsement":2,"name":"italian"},{"numOfEndorsement":2,"name":"Probiotics"},{"numOfEndorsement":2,"name":"probiotics"},{"numOfEndorsement":2,"name":"hts"},{"numOfEndorsement":2,"name":"high throughout screening "},{"numOfEndorsement":2,"name":"proteing desing"},{"numOfEndorsement":2,"name":"Euskera "},{"numOfEndorsement":0,"name":"Ingl\u00e9s comercial"},{"numOfEndorsement":0,"name":"Asuntos m\u00e9dicos"},{"numOfEndorsement":0,"name":"Enzimas"},{"numOfEndorsement":0,"name":"Inmunolog\u00eda"},{"numOfEndorsement":0,"name":"Espa\u00f1ol"},{"numOfEndorsement":0,"name":"Investigaci\u00f3n de mercado"},{"numOfEndorsement":0,"name":"Gesti\u00f3n de proyectos internacionales"},{"numOfEndorsement":0,"name":"Investigaci\u00f3n y desarrollo (I+D)"},{"numOfEndorsement":0,"name":"Desarrollo de procesos de producci\u00f3n"},{"numOfEndorsement":0,"name":"Startup"},{"numOfEndorsement":0,"name":"VGT"},{"numOfEndorsement":0,"name":"Cell therapy"},{"numOfEndorsement":0,"name":"AAV"},{"numOfEndorsement":0,"name":"CAR-T"},{"numOfEndorsement":0,"name":"Venture Capital"}],"numOfConnections":1239,"patents":[],"headline":"Customer Application Consultant for Emerging Biotech (Spain, Italy & Portugal) || Biotechnology & Bioeconomy","courses":[],"certifications":[{"authority":"Cambridge English Language Assessment","name":"First Certificate of English","company":"urn:li:fs_salesCompany:785621","startedOn":{"month":3,"year":2014},"companyUrn":"urn:li:fs_salesCompany:785621"},{"authority":"UPV\/EHU :: FCT-ZTF","name":"Nivel C1 euskera","company":"urn:li:fs_salesCompany:10059347","startedOn":{"year":2015},"companyUrn":"urn:li:fs_salesCompany:10059347"},{"authority":"C\u00f3digo No Verbal","name":"Curso Comunicaci\u00f3n No Verbal Y Oratoria","company":"urn:li:fs_salesCompany:10906371","startedOn":{"month":11,"year":2019},"companyUrn":"urn:li:fs_salesCompany:10906371"}],"memberBadges":{"premium":true,"openLink":false,"jobSeeker":false},"flagshipProfileUrl":"https:\/\/www.linkedin.com\/in\/i%C3%B1igo-de-la-fuente-cantalapiedra-592577b7","organizations":[],"location":"Madrid, Community of Madrid, Spain","publications":[],"positions":null,"posts":[{"createdAt":1716457260000,"insightId":"946013f4-7fc7-45b6-a1fd-72304e467b72","activityUnion":{"postActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7199343573857644544","threadUrn":"urn:li:activity:7199343573857644544","reactionsCount":1,"commentsCount":0,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7199343573262045184","message":{"attributes":[{"start":80,"length":9,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:466239"}}}],"text":"More tools for your viral-gene therapy to success thanks for the acquisition of Mirus Bio! GMP transfection reagents ready to improve your upstream together with our GMP cell culture media! Let\u00b4s bring this innovations, together, to the patients!"},"rootActivity":{"contentSummaryUnion":{"ingestedContentSummary":{"image":{"attributes":[{"originalImageUrl":"https:\/\/media.licdn.com\/dms\/image\/D4E22AQHELP4F7oRmwQ\/feedshare-shrink_2048_1536\/0\/1716400277325?e=1720051200&v=beta&t=dnejQZSRBSkdIQHp1Q5DwlRtCpZXVEyiLX7ovP8fNPY","sourceType":"URL","imageUrl":"https:\/\/media.licdn.com\/dms\/image\/D4E22AQHELP4F7oRmwQ\/feedshare-shrink_2048_1536\/0\/1716400277325?e=1720051200&v=beta&t=dnejQZSRBSkdIQHp1Q5DwlRtCpZXVEyiLX7ovP8fNPY"}]},"description":"Merck Signs Definitive Agreement to Acquire Life Science Company Mirus Bio for US$ 600 million","resolvedUrl":"https:\/\/www.merckgroup.com\/en\/news\/definite-agreement-mirus-bio-22-05-2024.html","title":"Definite-Agreement-Mirus-Bio | Merck"}},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7199105595390476290","message":{"attributes":[{"length":18,"start":512,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:16233341"}}},{"length":24,"start":540,"value":{"com.linkedin.common.HyperlinkAttributedEntity":{"url":"https:\/\/lnkd.in\/eeF5HfRf"}}}],"text":"Merck has signed a definitive agreement to acquire life science company Mirus Bio for US$ 600 million (around \u20ac 550 million). Mirus Bio is a specialist in the development and commercialization of transfection reagents. These reagents play a key role in the production of viral vectors for cell and gene therapies. The acquisition will advance our integrated offering for viral vector manufacturing and complements the existing portfolio for development and production of novel modalities \u2013 a key growth area for Merck Life Science. \n\nMore: https:\/\/lnkd.in\/eeF5HfRf\n\n[\ud83d\udcf7 from our Carlsbad, California manufacturing facility]"},"entityUrn":"urn:li:share:7199105595390476290"},"entityUrn":"urn:li:share:7199343573262045184"}}},{"createdAt":1716215220000,"insightId":"30cca09d-dc3b-4970-9130-c9a692e591f0","activityUnion":{"postActivity":{"contentSummaryUnion":{"referenceContentSummary":{"entityUrn":"urn:li:multiPhoto:1000184751777"}},"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":43},{"type":"PRAISE","count":7},{"type":"EMPATHY","count":4}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:ugcPost:7198328385889062914","threadUrn":"urn:li:ugcPost:7198328385889062914","reactionsCount":54,"commentsCount":1,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7198328385889062914","message":{"attributes":[{"start":78,"length":22,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:18971638"}}},{"start":199,"length":12,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:489902233"}}},{"start":216,"length":11,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:681048755"}}},{"start":385,"length":21,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:846220541"}}},{"start":411,"length":22,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:836703231"}}},{"start":534,"length":16,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:emergingbiotech"}}}],"text":"Let\u00b4s toast for great trials!\ud83e\udd42\ud83d\udd2c \n\nLast week we had the pleasure to join the LentiStem Biotech S.L. in the wonderful Granada. With Sierra Nevada and the Alhambra watching us and with the support of Marco Barrio and Carla Eller we were able to perform some trials to help the company in the purification of their Lentivirus platform with promising results! \ud83d\udc69\u200d\ud83d\udd2c\ud83d\udc68\u200d\ud83d\udd2c\n\nThanks a lot to Mar\u00eda Trist\u00e1n Manzano and Carmen Barbero Jim\u00e9nez for the hospitality, help & positive attitude! Let\u00b4s bring this therapies to patients together with #EmergingBiotech \ud83d\udcaa\n"},"entityUrn":"urn:li:ugcPost:7198328385889062914"}}},{"createdAt":1715070420000,"insightId":"d3c78eff-a1bf-4fd6-8607-e57b790e713c","activityUnion":{"postActivity":{"contentSummaryUnion":{"ingestedContentSummary":{"image":{"attributes":[{"originalImageUrl":"https:\/\/media.licdn.com\/dms\/image\/sync\/D4D27AQEn2lHrvsVcVg\/articleshare-shrink_800\/0\/1715069707092?e=1717977600&v=beta&t=BgUXkAc9Rju8p3q1di38PRAgiQ3mwWe60mjqMBXzDzs","sourceType":"URL","imageUrl":"https:\/\/media.licdn.com\/dms\/image\/sync\/D4D27AQEn2lHrvsVcVg\/articleshare-shrink_800\/0\/1715069707092?e=1717977600&v=beta&t=BgUXkAc9Rju8p3q1di38PRAgiQ3mwWe60mjqMBXzDzs"}]},"description":"Background Quorum sensing (QS) is a sophisticated cell-to-cell signalling mechanism that allows the coordination of important processes in microbial populations. The AI-1 and AI-2 autoinducer systems are among the best characterized bacterial QS...","resolvedUrl":"https:\/\/link.springer.com\/article\/10.1186\/s12864-024-10355-6?utm_source=rct_congratemailt&utm_medium=email&utm_campaign=oa_20240503&utm_content=10.1186%2Fs12864-024-10355-6","title":"Quorum sensing in bacteria: in silico protein analysis, ecophysiology, and reconstruction of their evolutionary history - BMC Genomics"}},"socialMetadata":{"reactionTypeCounts":[{"type":"PRAISE","count":11},{"type":"APPRECIATION","count":2},{"type":"LIKE","count":17},{"type":"EMPATHY","count":3}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7193526832787316736","threadUrn":"urn:li:activity:7193526832787316736","reactionsCount":33,"commentsCount":3,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7193526831210213377","message":{"attributes":[{"start":0,"length":24,"value":{"com.linkedin.common.HyperlinkAttributedEntity":{"url":"https:\/\/lnkd.in\/dM2mk_wK"}}},{"start":180,"length":14,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:183482850"}}}],"text":"https:\/\/lnkd.in\/dM2mk_wK\n\nMy second peer review paper (first as First author!!!) has finally been published! \ud83c\udf89\n\nIt\u00b4s been a journey since I had a discussion in the cafeteria with Jorge Barriuso (late 2017!!) and when it finally came out, but I can\u00b4t be more proud of it. Thanks to Jorge and the rest of the colleagues that collaborated and worked in it. \ud83d\udc68\u200d\ud83d\udd2c\ud83d\udc69\u200d\ud83d\udd2c\n\nA little bit of metagenomics, a bit of ecology and quorum sensing (QS), we searched in JGI data base different QS related genes in relevant microorganism and then related their ecological niche and behavour and the structure of their QS related proteins. \ud83e\uddec\ud83d\udd2c\n\nMy lab research days are gone now, but my science mind is stile quite alive! \ud83e\uddea\ud83d\udd0d\n"},"entityUrn":"urn:li:share:7193526831210213377"}}},{"createdAt":1712846820000,"insightId":"46dde3be-de1b-4406-b0ca-95880841b56d","activityUnion":{"postActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":2}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7184200477088047105","threadUrn":"urn:li:activity:7184200477088047105","reactionsCount":2,"commentsCount":0,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7184200476492500992","message":{"attributes":[],"text":"Italian and Spanish speaker? love bio(techno)logy and strong scientific background?\nApply to this great opportunity! Marta loved it and I\u00b4m sure you will too!\n"},"rootActivity":{"contentSummaryUnion":{"ingestedContentSummary":{"image":{"attributes":[{"originalImageUrl":"https:\/\/media.licdn.com\/dms\/image\/sync\/D4E27AQGUXU8gQqEMgw\/articleshare-shrink_800\/0\/1712819704455?e=1717977600&v=beta&t=BQ2jekXejdKsMR9x7eb3pHgQCaj8kxLCeQ8tYFoFBV0","sourceType":"URL","imageUrl":"https:\/\/media.licdn.com\/dms\/image\/sync\/D4E27AQGUXU8gQqEMgw\/articleshare-shrink_800\/0\/1712819704455?e=1717977600&v=beta&t=BQ2jekXejdKsMR9x7eb3pHgQCaj8kxLCeQ8tYFoFBV0"}]},"description":"Dans le cadre de votre mission, vous intervenez au sein de l'\u00e9quipe support technique. Vous \u00eates l'interlocuteur r\u00e9f\u00e9rent, sp\u00e9cialiste en Sciences d...","fullText":"Dans le cadre de votre mission, vous intervenez au sein de l'\u00e9quipe support technique. Vous \u00eates l'interlocuteur r\u00e9f\u00e9rent, sp\u00e9cialiste en Sciences de la vie au sein d'une \u00e9quipe multidisciplinaire. Vous \u00e9luciderez les probl\u00e8mes scientifiques et r\u00e9pondrez \u00e0 des questions hautement techniques sur les produits et leurs applications. Vous r\u00e9pondrez \u00e0 des requ\u00eates techniques, de l'optimisation de protocole, ou encore au niveau de r\u00e9clamation sur la qualit\u00e9 des produits pour la microbiologie. Vous contribuerez ainsi au d\u00e9veloppement du chiffre d'affaires en identifiant et qualifiant les besoins client. Vous serez amen\u00e9 \u00e0 dispenser des formations dans votre domaine d'expertise, \u00e0 participer ponctuellement \u00e0 des visites clients ou encore \u00e0 des congr\u00e8s afin de promouvoir les produits de la soci\u00e9t\u00e9. De formation Bac+3\/Bac+5 en Biologie\/Microbiologie ou domaine technique \u00e9quivalent, vous justifiez d'une premi\u00e8re exp\u00e9rience en laboratoire. Vous parlez couramment espagnol et italien, et avez un bon niveau en anglais (oral et \u00e9crit). Toute autre langue europ\u00e9enne sera appr\u00e9ci\u00e9e. Vous \u00eates bon communicant, motiv\u00e9 par le travail au sein d'une \u00e9quipe multiculturelle et d'un environnement international et tr\u00e8s dynamique. Vous \u00eates orient\u00e9 satisfaction client avec une forte capacit\u00e9 d'\u00e9coute et de communication ainsi qu'une grande habilit\u00e9 \u00e0 identifier les besoins du client. Vous \u00eates garant d'une exp\u00e9rience client optimale. Vous \u00eates enthousiaste \u00e0 l'id\u00e9e d'\u00e9tendre votre expertise dans de nouvelles technologies et t\u00e9moignez d'un esprit cr\u00e9atif, avec un sens aigu d'investigation et de r\u00e9solution de probl\u00e8mes. Nous recherchons pour le compte de notre client un Conseiller scientifique en microbiologie (F\/H) ajouter aux favoris envoyer par email","resolvedUrl":"https:\/\/www.expectra.fr\/offre\/307-ust-0001399_01c\/conseiller_scientifique_en_microbiologie_f_h_\/","title":"Expectra recrute : CONSEILLER SCIENTIFIQUE EN MICROBIOLOGIE (F\/H)","sourceDomain":"expectra.fr"}},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7184088428546826240","message":{"attributes":[{"start":218,"length":24,"value":{"com.linkedin.common.HyperlinkAttributedEntity":{"url":"https:\/\/lnkd.in\/ekyP996Y"}}}],"text":"My Team at Merck is currently looking for a Technical Service Scientist covering our microbiology portfolio, for a one year mission. See official announcement in the link below. \nLet me know if you are interested \ud83d\ude03 \n\nhttps:\/\/lnkd.in\/ekyP996Y"},"entityUrn":"urn:li:share:7184088428546826240"},"entityUrn":"urn:li:share:7184200476492500992"}}},{"createdAt":1712568960000,"insightId":"b9347351-59d1-4ec5-98c0-3ba18e21589b","activityUnion":{"postActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":2}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:ugcPost:7183034883324166144","threadUrn":"urn:li:ugcPost:7183034883324166144","reactionsCount":2,"commentsCount":0,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7183034883324166144","message":{"attributes":[],"text":"Are you facing challenges in your Upstream process development?\nDo you want an extra pair of hands, and more important, brains, to help you with your process development ? \nReach out and let\u00b4s find the best solution together!"},"rootActivity":{"contentSummaryUnion":{"mediaContentSummary":{"title":{"text":""},"mediaType":"VIDEO","thumnailUrl":"https:\/\/dms.licdn.com\/playlist\/vid\/D4E10AQEsPsEtMkyR0A\/videocover-firstframe-low\/0\/1712566969886?e=1717977600&v=beta&t=W_pL7OC_Te7FQoqSrVCfl9g1OZiRKh9acUbNJvVPCBk"}},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7183026520393682944","message":{"attributes":[{"start":225,"length":24,"value":{"com.linkedin.common.HyperlinkAttributedEntity":{"url":"https:\/\/lnkd.in\/eykpmHwP"}}},{"start":253,"length":15,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:upstreamtrials"}}},{"start":269,"length":19,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:processdevelopment"}}}],"text":"\ud83c\udf1fWe're thrilled to unveil our cutting-edge upstream capabilities at our M Lab\u2122 Collaboration Centers. \nOur dedicated team is here to collaborate with you every step of the way.\ud83e\udd1d\nConnect with our experts by clicking here  . https:\/\/lnkd.in\/eykpmHwP . \n#UpstreamTrials #ProcessDevelopment"},"entityUrn":"urn:li:ugcPost:7183026520393682944"},"entityUrn":"urn:li:ugcPost:7183034883324166144"}}},{"createdAt":1712150820000,"insightId":"6f4976d3-1195-410f-bc6c-210476d22a30","activityUnion":{"postActivity":{"contentSummaryUnion":{"ingestedContentSummary":{"description":"Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on Fierce Biotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D.","resolvedUrl":"http:\/\/fiercebiotech.com","title":"Fierce Biotech News & Reports"}},"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":3}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7181281246319157248","threadUrn":"urn:li:activity:7181281246319157248","reactionsCount":3,"commentsCount":0,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7181281245492830209","message":{"attributes":[{"start":429,"length":12,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:genetherapy"}}},{"start":442,"length":18,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:biotechinnovation"}}},{"start":461,"length":16,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:emergingbiotech"}}}],"text":"Ring Therapeutics has developed a promising gene therapy delivery system using anellovirus-based vectors, showing successful gene delivery to mouse retinas with stable expression for nine months. \ud83e\uddec \nThis breakthrough offers potential advantages over traditional adeno-associated virus (AAV) vectors. The company's innovative approach and upcoming investigational studies signal exciting progress in gene therapy development. \ud83d\udca1 #GeneTherapy #BiotechInnovation #EmergingBiotech"},"entityUrn":"urn:li:share:7181281245492830209"}}},{"createdAt":1710836640000,"insightId":"dd755b4f-220c-4cae-8fd8-2b2c35e33ac5","activityUnion":{"postActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":17},{"type":"EMPATHY","count":2}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7175769021303111683","threadUrn":"urn:li:activity:7175769021303111683","reactionsCount":19,"commentsCount":0,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7175769020783017986","message":{"attributes":[{"start":10,"length":25,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:836285"}}},{"start":182,"length":15,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:39420679"}}},{"start":199,"length":21,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:337826852"}}},{"start":225,"length":22,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:154298342"}}}],"text":"Thanks to CataloniaBio & HealthTech for organizing such an interactive and enjoyable event. High quality speakers and the best of the biotech ecosystem in just one place! \nThanks to Albert Portol\u00e9s, Marta Diez Castellnou and Sylviane BAGHDASSARIAN for making this possible. "},"rootActivity":{"contentSummaryUnion":{"mediaContentSummary":{"mediaType":"STILLIMAGE","thumnailUrl":"https:\/\/media.licdn.com\/dms\/image\/D4D22AQENn9n0GmbgYA\/feedshare-shrink_2048_1536\/0\/1710778282987?e=1720051200&v=beta&t=C6i-n5R3B-EhdXOzWxn4EiSNJp-zZdjhXSputWkLgLE"}},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7175524199795486720","message":{"attributes":[{"start":45,"length":18,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:nitcataloniabioht"}}},{"start":84,"length":18,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:16233341"}}},{"start":113,"length":15,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:39420679"}}},{"start":133,"length":18,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:416454014"}}},{"start":165,"length":25,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:836285"}}}],"text":"Last week, I had the pleasure of joining the #NitCataloniaBioHT event, representing Merck Life Science alongside Albert Portol\u00e9s and I\u00f1igo De la Fuente. \n\nThanks to CataloniaBio & HealthTech for organizing such a fantastic event where we discussed the future of the pharma and biotech industry. \n\nLooking forward to next year! \ud83d\ude03 "},"entityUrn":"urn:li:share:7175524199795486720"},"entityUrn":"urn:li:share:7175769020783017986"}}},{"createdAt":1716455580000,"insightId":"7c2c890a-0ab6-4a2a-9652-0e58533772cf","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7199303086060748801,7199336638055878656)","threadUrn":"urn:li:activity:7199303086060748801","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":106,"length":12,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:91824975"}}}],"text":"I\u00b4m wondering about the out-of-the-box questions they , for sure, did it to you! Lovely idea & experience Mark Peacock"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7199303086060748801"}}},{"createdAt":1716196920000,"insightId":"7096df3c-45b5-4b5d-bee2-7a852de044c4","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"PRAISE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7196841902166405122,7198251852440727552)","threadUrn":"urn:li:ugcPost:7196841902166405122","reactionsCount":1,"commentsCount":1,"canComment":true},"commentary":{"attributes":[],"text":"el ejercicio m\u00e1s dif\u00edcil de todos estos para mi es hacer el premortem! El \"Si todo saliese mal\"  o \"\u00bfqu\u00e9 es mas probable que salga mal?\" son preguntas m\u00e1s dif\u00edciles de responder de lo que parece, y a veces un ejercicio cuestinable a la hora de  juzgarlo... en un entorno cambiante, es muy probable que no podamos ver venir esos retos! "},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7196841902166405122"}}},{"createdAt":1715088840000,"insightId":"c33d33b6-372f-430d-91d7-800ee0af5307","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7193526832787316736,7193604211979304963)","threadUrn":"urn:li:activity:7193526832787316736","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":7,"length":13,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:46480735"}}}],"text":"Thanks Andrew Carass! Long run work pays off!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7193526832787316736"}}},{"createdAt":1715067240000,"insightId":"a503518b-2b07-4bf2-8b3b-26492386f501","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7193147705324421120,7193513460234649601)","threadUrn":"urn:li:ugcPost:7193147705324421120","reactionsCount":1,"commentsCount":1,"canComment":true},"commentary":{"attributes":[{"start":41,"length":25,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:641233495"}}}],"text":"I just hear about it yesterday! Congrats Pedro Luis Justicia Lirio!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7193147705324421120"}}},{"createdAt":1714056600000,"insightId":"07983613-6495-4ebd-b645-805c73efe715","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7189191449266053120,7189274597001748480)","threadUrn":"urn:li:activity:7189191449266053120","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":91,"length":19,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:577056272"}}}],"text":"Such a lovely memories from my time at @VITO! Hope you had a great time working with them, Elena Bueno Avent\u00edn"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7189191449266053120"}}},{"createdAt":1713969300000,"insightId":"c71955a7-0af6-4383-902e-6a37cc4120e7","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7188878118433009665,7188908360618950656)","threadUrn":"urn:li:activity:7188878118433009665","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"all great proyects indeed! and quite different from each other! "},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7188878118433009665"}}},{"createdAt":1713946020000,"insightId":"e93ce6b4-5796-47d0-ab70-91d565412344","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7188791887212802048,7188810892346593280)","threadUrn":"urn:li:ugcPost:7188791887212802048","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"A ver, contra un 1% las posibilidades de salir ganando no eran tan malas...\nUn Rolero como yo tambi\u00e9n hubiese aceptado un tercio de 2 dados de 6 caras. Casi tiene la misma arbitrariedad. "},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7188791887212802048"}}},{"createdAt":1713517500000,"insightId":"d23e9987-5d65-435c-ab8f-f9682cbe2a2d","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7186614491990671360,7187013517512761345)","threadUrn":"urn:li:ugcPost:7186614491990671360","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Opinion: si est\u00e1s delante de cliente, eres ventas. Field marketing es soporte a venta o venta tecnica\/especializada. "},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7186614491990671360"}}},{"createdAt":1713511740000,"insightId":"8ec60ebd-687c-44fc-8132-a31425e2866e","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"EMPATHY","count":1},{"type":"PRAISE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7186816909978288130,7186989337501155330)","threadUrn":"urn:li:activity:7186816909978288130","reactionsCount":2,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"que proyecto m\u00e1s bonito! Enhorabuena Mireya!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7186816909978288130"}}},{"createdAt":1713445860000,"insightId":"c4d348da-9b3b-43e7-962a-b7a7c97a30b2","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7186071032758210560,7186712959769866240)","threadUrn":"urn:li:activity:7186071032758210560","reactionsCount":0,"commentsCount":1,"canComment":true},"commentary":{"attributes":[],"text":"Honestly, we all know that if the company did not go for several disastrously years of results they would not even consider it... But desperate times call for desperate actions.  "},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7186071032758210560"}}},{"createdAt":1713445500000,"insightId":"84a9484b-68d0-4cd4-ade7-4eada0334ce1","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7186651282932137985,7186711370359328768)","threadUrn":"urn:li:activity:7186651282932137985","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":57,"length":17,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:378601688"}}}],"text":"Love this technology and all it\u00b4s aplications! great job Laurens Vergauwen"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7186651282932137985"}}},{"createdAt":1712564220000,"insightId":"d86c173f-003e-415c-8aaf-015726db338e","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"EMPATHY","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7177613063808827392,7183014991690686465)","threadUrn":"urn:li:ugcPost:7177613063808827392","reactionsCount":1,"commentsCount":1,"canComment":true},"commentary":{"attributes":[],"text":"recomendaciones de libros siempre es BIEN. \n"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7177613063808827392"}}},{"createdAt":1712238660000,"insightId":"063923f2-af82-4f5c-80c6-2cd1386fb942","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7181605000307957760,7181649498023084033)","threadUrn":"urn:li:ugcPost:7181605000307957760","reactionsCount":0,"commentsCount":1,"canComment":true},"commentary":{"attributes":[{"start":12,"length":5,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:256424208"}}}],"text":"Felicidades Manel! Gran y bonito reto el navegar el crecimiento de Vytrus! mucha suerte!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7181605000307957760"}}}]}